Review



place conditioning apparatus 4  (AutoMate Scientific Inc)


Bioz Verified Symbol AutoMate Scientific Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    AutoMate Scientific Inc place conditioning apparatus 4
    Place Conditioning Apparatus 4, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 96/100, based on 17 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/place+conditioning+apparatus+4/CPP+Data+Collection+Utility/pm32791386-131-9-19
    Average 96 stars, based on 17 article reviews
    place conditioning apparatus 4 - by Bioz Stars, 2026-10
    96/100 stars

    Images

    Related Articles

    other:

    Article Title: Hydrogel-mediated co-transplantation of retinal pigmented epithelium and photoreceptors restores vision in an animal model of advanced retinal degeneration.
    Article Snippet: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article.. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.



    Similar Products

    place conditioning apparatus 4  (AutoMate Scientific Inc)
    96
    AutoMate Scientific Inc place conditioning apparatus 4
    Place Conditioning Apparatus 4, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/place+conditioning+apparatus+4/CPP+Data+Collection+Utility/pm32791386-131-9-19
    Average 96 stars, based on 1 article reviews
    place conditioning apparatus 4 - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier
    place conditioning apparatus  (Med Associates Inc)
    96
    Med Associates Inc place conditioning apparatus
    Effects of high and low doses of BDNF on 5 and 15 mg/kg morphine-conditioned place preferences in mice. a, Infusions of 0.025 μg BDNF (same dose used in rats by Vargas-Perez et al. (2009b)) or 0.25 μg BDNF (dose used by Koo et al. (2012)) in mouse VTA did not abolish 5 mg/kg morphine place preferences, but resulted in a switch to a DA-dependent motivational state wherein α-flupenthixol blocks the conditioned place preferences. b, Infusions of 0.25 μg BDNF in mouse VTA did not abolish 15 mg/kg morphine-conditioned place preferences, even when the duration of <t>conditioning</t> sessions was extended to 45 min to match the conditions used by Koo et al. (2009). c, Infusions of 0.25 μg BDNF in mouse VTA did not abolish 15 mg/kg morphine preferences even after using the same conditioned place preference paradigm and VTA coordinates used by Koo et al. (2012); *p values <0.05.
    Place Conditioning Apparatus, supplied by Med Associates Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/place+conditioning+apparatus+4/CPP+Data+Collection+Utility/pmc04099491-396-1-4
    Average 96 stars, based on 1 article reviews
    place conditioning apparatus - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of high and low doses of BDNF on 5 and 15 mg/kg morphine-conditioned place preferences in mice. a, Infusions of 0.025 μg BDNF (same dose used in rats by Vargas-Perez et al. (2009b)) or 0.25 μg BDNF (dose used by Koo et al. (2012)) in mouse VTA did not abolish 5 mg/kg morphine place preferences, but resulted in a switch to a DA-dependent motivational state wherein α-flupenthixol blocks the conditioned place preferences. b, Infusions of 0.25 μg BDNF in mouse VTA did not abolish 15 mg/kg morphine-conditioned place preferences, even when the duration of conditioning sessions was extended to 45 min to match the conditions used by Koo et al. (2009). c, Infusions of 0.25 μg BDNF in mouse VTA did not abolish 15 mg/kg morphine preferences even after using the same conditioned place preference paradigm and VTA coordinates used by Koo et al. (2012); *p values <0.05.

    Journal: The Journal of Neuroscience

    Article Title: BDNF Signaling in the VTA Links the Drug-Dependent State to Drug Withdrawal Aversions

    doi: 10.1523/JNEUROSCI.3776-13.2014

    Figure Lengend Snippet: Effects of high and low doses of BDNF on 5 and 15 mg/kg morphine-conditioned place preferences in mice. a, Infusions of 0.025 μg BDNF (same dose used in rats by Vargas-Perez et al. (2009b)) or 0.25 μg BDNF (dose used by Koo et al. (2012)) in mouse VTA did not abolish 5 mg/kg morphine place preferences, but resulted in a switch to a DA-dependent motivational state wherein α-flupenthixol blocks the conditioned place preferences. b, Infusions of 0.25 μg BDNF in mouse VTA did not abolish 15 mg/kg morphine-conditioned place preferences, even when the duration of conditioning sessions was extended to 45 min to match the conditions used by Koo et al. (2009). c, Infusions of 0.25 μg BDNF in mouse VTA did not abolish 15 mg/kg morphine preferences even after using the same conditioned place preference paradigm and VTA coordinates used by Koo et al. (2012); *p values <0.05.

    Article Snippet: The place conditioning apparatus (Med-Associates SOF-700RA-25) used consisted of a black compartment with metal rod floor, a white compartment with a wire mesh floor, and a gray compartment in the middle that contained a partition on both sides.

    Techniques: Conditioned Place Preference

    Motivational effects of withdrawal in opiate-dependent animals after blocking BDNF function in the VTA. a, Knocking down TrkB in the VTA with LV-siRNAs did not affect spontaneous opiate somatic withdrawal signs. Both LV-siRNAs (n = 8) and LV-GFP (n = 8) animals show an increase in percentage abstinence scores over time after 16 h heroin administration with respect to saline control animals (n = 8; *p < 0.05). b, Opiate naive (n = 7) and dependent (n = 7) LV-siRNAs-treated animals display a reduction in low-frequency (22 kHz) s compared with opiate naive (n = 7) and dependent (n = 7) LV-GFP-treated animals (*p < 0.05) during naloxone-precipitated chronic opiate withdrawal during the course of a 10 min test session. c, Knocking down TrkB in the VTA with LV-siRNAs blocks the place aversion for 16 h of abstinence from morphine (3 mg/kg) in dependent rats (n = 8). In contrast, control opiate-dependent animals infected with LV-GFP (n = 8) show conditioned place aversions (*p < 0.05). d, Naloxone-conditioned (5 mg/kg) place aversions were blocked in LV-siRNAs-treated (n = 8) dependent animals, but not in LV-GFP-treated (n = 8) animals (*p < 0.05). e, Both LV-siRNAs (n = 8) and LV-GFP (n = 8)-infected animals display a conditioning place aversion to LiCl (5 mg/kg; *p < 0.05). Data represent the means ± SEM the absolute times spent in the previously saline and previously drug paired compartments.

    Journal: The Journal of Neuroscience

    Article Title: BDNF Signaling in the VTA Links the Drug-Dependent State to Drug Withdrawal Aversions

    doi: 10.1523/JNEUROSCI.3776-13.2014

    Figure Lengend Snippet: Motivational effects of withdrawal in opiate-dependent animals after blocking BDNF function in the VTA. a, Knocking down TrkB in the VTA with LV-siRNAs did not affect spontaneous opiate somatic withdrawal signs. Both LV-siRNAs (n = 8) and LV-GFP (n = 8) animals show an increase in percentage abstinence scores over time after 16 h heroin administration with respect to saline control animals (n = 8; *p < 0.05). b, Opiate naive (n = 7) and dependent (n = 7) LV-siRNAs-treated animals display a reduction in low-frequency (22 kHz) s compared with opiate naive (n = 7) and dependent (n = 7) LV-GFP-treated animals (*p < 0.05) during naloxone-precipitated chronic opiate withdrawal during the course of a 10 min test session. c, Knocking down TrkB in the VTA with LV-siRNAs blocks the place aversion for 16 h of abstinence from morphine (3 mg/kg) in dependent rats (n = 8). In contrast, control opiate-dependent animals infected with LV-GFP (n = 8) show conditioned place aversions (*p < 0.05). d, Naloxone-conditioned (5 mg/kg) place aversions were blocked in LV-siRNAs-treated (n = 8) dependent animals, but not in LV-GFP-treated (n = 8) animals (*p < 0.05). e, Both LV-siRNAs (n = 8) and LV-GFP (n = 8)-infected animals display a conditioning place aversion to LiCl (5 mg/kg; *p < 0.05). Data represent the means ± SEM the absolute times spent in the previously saline and previously drug paired compartments.

    Article Snippet: The place conditioning apparatus (Med-Associates SOF-700RA-25) used consisted of a black compartment with metal rod floor, a white compartment with a wire mesh floor, and a gray compartment in the middle that contained a partition on both sides.

    Techniques: Blocking Assay, Saline, Control, Infection